Overview
Drug Discovery
News
RTCA Instrument
E-Plate
CIM-Plate
Software
Overview
Cases
Principle
Patent
Advantages
Cell Index
Overview
Dissertation
Notes
Documentation
Overview
Careers
Contact
Feedback
Partner
中国
United States
Product
News
Literature
Other
Home
About ACEA
Products
Application
Technology
Collaboration
Literature
HR
Contact Us
About ACEA
Overview
Drug Discovery
News
ACEA News
Trends
Hot News
the Early Detection of
Cellular Dynamics Inte
Quantitative Assessmen
Vivo Biosciences, ACEA
The xCELLigence RTCA C
Home
> About ACEA > ACEA News
ACEA Biosciences Announces Co-Chairmen Board of Directors elects Jixun Lin and Feng Lin
[2011-04-25]
ACEA Biosciences, Inc. Announces New Patent; Broad Claims Granted for Cytotoxicity Profiling and Chemical Compound Testing
[2011-02-07]
ACEA BIOSCIENCES SELECTED FOR IRS QUALIFYING THERAPEUTIC DISCOVERY GRANT
[2010-11-04]
Quantitative Assessment of Clostridium Difficile Toxin by Real Time Cell Analysis
[2010-11-03]
Vivo Biosciences, ACEA Biosciences, and Roche to develop new xCELLigence System assays for stem cell and cancer research
[2010-10-06]
Roche’s new RTCA Cardio Instrument for label-free functional cardiomyocyte toxicity testing
[2010-09-28]
The xCELLigence RTCA Cardio System
[2010-09-16]
Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes on the xCELLigence System
[2010-09-16]
RTCA Cardiotoxicity testing system
[2010-06-18]
ACEA Biosciences, Inc., announces a major breakthrough in cardiotoxicity testing and limited-time free-access to customers
[2010-06-18]
the Early Detection of Hepatic Cytotoxicity
[2010-06-10]
Fast Track
Solutions
Usinghelp
Contact Us
Q&A
Feedback
HR